Advanced Oncotherapy plc announced that it has received £3.8626 million in funding

Advanced Oncotherapy Plc is a United Kingdom-based specialist developer and provider of a proton therapy system, the LIGHT system. The Company’s team, ADAM, based in Geneva, is focused on the development of a proprietary proton accelerator called, Linac Image Guided Hadron Technology (LIGHT). LIGHT's compact configuration delivers proton beams in a way that facilitates greater precision and electronic control. The linear design of LIGHT allows for active longitudinal modulation along the proton beam axis and the variation of the proton beam by electronic means during cancer treatment. The modular feature of LIGHT offers hospitals and treatment centers the flexibility to customize cancer treatment plans based on a range of energies. Its subsidiaries include ADAM S.A., Advanced Oncotherapy Americas Inc, Advanced Oncotherapy B.V., Advanced Oncotherapy Resources Ltd, APTS Harley Street Ltd, Advanced Oncotherapy (China) Ltd, Advanced Oncotherapy Proton Therapy Services Ltd and other.